1. Why should we do this study?
Having eczema can have a big impact on people’s lives and because there is no cure, we would like to find a way to prevent eczema developing in children. We don’t know whether adding in emollients to the skin care advice given to parents is effective in preventing eczema, and the only way to find out is by doing this study.
2. How many families will take part in the BEEP study?
1300 families with newborn babies who have asthma, eczema or hayfever in the immediate family are taking part in this study.
3. Who is eligible to take part?
families who are expecting a baby, and where at least one person in the immediate family has (or had in the past) eczema, asthma or hayfever.
Please note, recruitment to the study has now closed.
4. How long will the study last for?
Recruitment to the study has now closed. Results are expected in early 2019.
5. What is involved in taking part?
Each family will take part in the study for up to 5 years. The study nurse will carry out a skin assessment when your child is around 2 years of age and this can either be at your home or the hospital, whichever you prefer. We will also ask each family to fill in some short questionnaires approximately once or twice a year until your child’s fifth birthday. Although this may seem like a long time, it is important that we look at the long term effectiveness to answer the question properly.
6. Where is the study taking place?
The BEEP study is taking place in the following areas:
7. Who is funding the study?
Recruitment has now reached the overall target of 1282 participants, so we are not able to accept any more families onto the BEEP study. Many thanks to all families who are taking part and any who expressed an interest but were unable to participate. Please do contact us if you are not taking part but would like to receive a copy of the results.
How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies
BEEP Study protocol registered
On 25th July 2014, the BEEP study protocol was registered on the ISRCTN clinical trial registry. The unique identifier is ISRCTN21528841.
BEEP study given ethical approval to go ahead
On the 9th June 2014, the ethics committee (NRES Committee West Midlands – Solihull) gave approval for the BEEP study to go ahead (reference 14/WM/0162)
Find out more
To find out more, please email us on email@example.com or telephone 0115 884 4937.